Ex-PRESS mini glaucoma shunt (Optonol Ltd., Neve Ilan, Israel)
Record ID 32010000972
English
Authors' objectives:
Glaucoma refers to a group of optic disorders in which vision is lost and the optic nerve is damaged. In the United States, glaucoma affects approximately 2.5 million individuals who are 55 years of age and older, making it the second most common cause of blindness. Although glaucoma cannot be prevented, treatments to slow the progression of the disease are available. Treatment of glaucoma usually includes eye drops and/or oral medications that reduce intraocular pressure, the fluid pressure inside each eye. Glaucoma treatment may also require laser or incision surgery to open or remove blocked drainage canals inside affected eyes.
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Intraocular Pressure
- Stents
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.